| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5825736 | Clinical Therapeutics | 2011 | 9 Pages |
Abstract
In this analysis, BIAsp-30 was associated with improved glycemic control (HbA1c) compared with BHI-30 in insulin-naive patients with type 1 or type 2 diabetes and insulin-experienced patients with type 2 diabetes. BIAsp-30 was associated with reduced hypoglycemia in insulin-naive patients with type 2 diabetes and lower rates of treatment discontinuation in insulin-experienced patients with type 2 diabetes. Cambridgeshire Research Ethics Committee: REC 08/H0305/47.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Christopher Ll. MSc, Marc MD, Anders D. MD, Sara MSc, Chris D. PhD, Craig J. PhD,